Product Images Tri-estarylla

This text provides information on various studies related to women's contraceptive use, including their ever use and current use. The studies include the NICHD Women's Contraceptive Study from 2002, the French E3N cohort study from 2005, the Shangal Women's Health study from 2009, The Nurses' Health Study I from 2010, and the Oxford Family Planning Association Study from 2013. It also features information on the effect estimate (OR/RR) but lacks complete information as it references specific data points that are not clear.*

Ethinyl Estradiol is a synthetic estrogen commonly used in combination with a progestin as a component of hormonal contraceptives.*

This appears to be a chart displaying information about different birth control methods and their effectiveness in preventing pregnancy. It shows that fewer than 1 pregnancy occurs per 100 women per year for some methods, such as implants, injections, intrauterine devices, and sterilization. Other methods, such as birth control pills, skin patches, vaginal rings, condoms, and diaphragms have varying success rates in preventing pregnancy. The chart also includes suggestions for alternative methods, such as avoiding sex during the most fertile days of the monthly cycle, using spermicide, and practicing withdrawal.*

This is a medication called Norgestimate and Ethinyl Estradiol Tablets, USP containing different dosages of norgestimate and ethinyl estradiol. It comes in a package of 84 tablets with 3 sets of 28 blister cards. The white tablet contains 0.18 mg norgestimate and 0.035 mg of ethinyl estradiol while the active light blue tablet contains 0.215 mg norgestimate and 0.035 mg of ethinyl estradiol. The active blue tablet contains 0.25 mg norgestimate and 0.035 mg of ethinyl estradiol. The green tablet however does not contain active ingredients. It is important to keep the medication away from children as the package is not child resistant. The medication should also be stored at room temperature away from light.*